4.5 Article

Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

期刊

JOURNAL OF CLINICAL PSYCHIATRY
卷 72, 期 1, 页码 43-50

出版社

PHYSICIANS POSTGRADUATE PRESS
DOI: 10.4088/JCP.09m05094blu

关键词

-

资金

  1. Eli Lilly
  2. Bristol-Myers Squibb
  3. Somaxon
  4. Pfizer
  5. GlaxoSmithKline
  6. National Institutes of Health [AA000449, DA019606, DA020783, DA023200, MH076051, T32 MH016434, U18 HS016097, AA014223]
  7. Mental Health Initiative (MINT) Foundation
  8. American Foundation for Suicide Prevention
  9. New York State Psychiatric Institute
  10. AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016097] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016434, R01MH076051] Funding Source: NIH RePORTER
  12. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA014223, ZIAAA000449, Z01AA000449] Funding Source: NIH RePORTER
  13. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020783, R01DA019606, K02DA023200] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Objective: Although clinical studies have documented that specific anxiety disorders are associated with impaired psychosocial functioning, little is known regarding their comparative effects on health-related quality of life within a general population. The current analysis compares health-related quality of life in a US community-dwelling sample of adults with DSM-IV social anxiety disorder, generalized anxiety disorders (GAD), panic disorder, and specific phobia. Method: A face-to-face survey of a US nationally representative sample of over 43,000 adults aged 18 years and older residing in households and group quarters was conducted. Prevalence of DSM-IV anxiety disorders and relative associations with health-related quality of life indicators were examined. The survey was conducted from 2001 to 2002. Results: Roughly 9.8% of respondents met diagnostic criteria for at least 1 of 4 twelve-month DSM-IV anxiety disorders which, relative to the non-anxiety-disordered general population, were each associated with lower personal income, increased rates of 12-month physical conditions, and greater numbers of Axis I and Axis II DSM-IV psychiatric conditions. After adjusting for sociodemographic and clinical correlates, including other anxiety disorders, GAD was associated with significant decrements in the SF-12 mental component summary score. In similar models, GAD and, to a lesser extent, panic disorder were significantly associated with impairment in social functioning, role emotional, and mental health SF subscales. Conclusions: GAD, followed by panic disorder, appears to exact significant and independent tolls on health-related quality of life. Results underscore the importance of prompt and accurate clinical identification and improving access to effective interventions for these disorders. J Clin Psychiatry 2011;72(1)43-50 (C) Copyright 2010 Physicians Postgraduate Press, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据